Zurich Cantonal Bank’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-14,231
| Closed | -$659K | – | 2630 |
|
|
2019
Q2 | $659K | Buy |
14,231
+2,515
| +21% | +$70.6K | 0.01% | 870 |
|
|
2019
Q1 | $286K | Sell |
11,716
-2,063
| -15% | -$43K | ﹤0.01% | 1034 |
|
|
2018
Q4 | $196K | Hold |
13,779
| – | – | ﹤0.01% | 1217 |
|
|
2018
Q3 | $209K | Buy |
13,779
+1,334
| +11% | +$20.4K | ﹤0.01% | 1280 |
|
|
2018
Q2 | $209K | Hold |
12,445
| – | – | ﹤0.01% | 1217 |
|
|
2018
Q1 | $203K | Buy |
12,445
+3,201
| +35% | +$51.3K | ﹤0.01% | 1191 |
|
|
2017
Q4 | $118K | Buy |
9,244
+3,834
| +71% | +$43.6K | ﹤0.01% | 1480 |
|
|
2017
Q3 | $67K | Hold |
5,410
| – | – | ﹤0.01% | 1632 |
|
|
2017
Q2 | $45K | Hold |
5,410
| – | – | ﹤0.01% | 1837 |
|
|
2017
Q1 | $48K | Hold |
5,410
| – | – | ﹤0.01% | 1760 |
|
|
2016
Q4 | $48K | Hold |
5,410
| – | – | ﹤0.01% | 1728 |
|
|
2016
Q3 | $37K | Buy |
5,410
+1,344
| +33% | +$5.2K | ﹤0.01% | 1848 |
|
|
2016
Q2 | $14K | Hold |
4,066
| – | – | ﹤0.01% | 2270 |
|
|
2016
Q1 | $12K | Hold |
4,066
| – | – | ﹤0.01% | 2312 |
|
|
2015
Q4 | $17K | Buy |
4,066
+2,380
| +141% | +$10.9K | ﹤0.01% | 2193 |
|
|
2015
Q3 | $8K | Buy |
1,686
+1,088
| +182% | +$6.45K | ﹤0.01% | 2255 |
|
|
2015
Q2 | $4K | Hold |
598
| – | – | ﹤0.01% | 2099 |
|
|
2015
Q1 | $4K | Buy |
+598
| New | +$4.26K | ﹤0.01% | 2076 |
|
Other funds holding ARRY
Zurich Cantonal Bank's ARRY Position: Q3 2019 in Review
Zurich Cantonal Bank sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 14,231 shares — an estimated $659K sold.
Zurich Cantonal Bank first reported a position in ARRY in Q1 2015 and held it in 18 quarters. The position peaked at $659K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Zurich Cantonal Bank reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Zurich Cantonal Bank sold 14,231 Array Biopharma Inc shares in Q3 2019, an estimated $659K.
- Zurich Cantonal Bank first reported a position in Array Biopharma Inc in Q1 2015 and held it in 18 quarters.
- Zurich Cantonal Bank's Array Biopharma Inc position peaked at $659K in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Zurich Cantonal Bank's 13F filing for Q3 2019, filed 18 Oct 2019.